Guizhou Xinbang Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2021: 0.01%

Guizhou Xinbang Pharmaceutical Co Ltd (002390) has an Asset Resilience Ratio of 0.01% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Guizhou Xinbang Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.00 Million
≈ $146.33K USD Cash + Short-term Investments

Total Assets

CN¥9.61 Billion
≈ $1.41 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2017)

This chart shows how Guizhou Xinbang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See cash generation quality of Guizhou Xinbang Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Guizhou Xinbang Pharmaceutical Co Ltd's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.00 Million 0.01%
Total Liquid Assets CN¥1.00 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: Guizhou Xinbang Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Guizhou Xinbang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guizhou Xinbang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
Drug Manufacturers - Specialty & Generic 2.09%
Henan Taloph Pharmaceutical Stock Co Ltd
SHG:600222
Drug Manufacturers - Specialty & Generic 2.75%
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
Drug Manufacturers - Specialty & Generic 2.98%

Annual Asset Resilience Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2012–2017)

The table below shows the annual Asset Resilience Ratio data for Guizhou Xinbang Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-12-31 0.67% CN¥80.00 Million
≈ $11.71 Million
CN¥11.95 Billion
≈ $1.75 Billion
-0.63pp
2016-12-31 1.30% CN¥140.00 Million
≈ $20.49 Million
CN¥10.80 Billion
≈ $1.58 Billion
+0.53pp
2015-12-31 0.77% CN¥50.00 Million
≈ $7.32 Million
CN¥6.50 Billion
≈ $951.87 Million
+0.86pp
2014-12-31 -0.10% CN¥-4.99 Million
≈ $-729.90K
CN¥5.22 Billion
≈ $764.33 Million
-5.48pp
2013-12-31 5.38% CN¥80.00 Million
≈ $11.71 Million
CN¥1.49 Billion
≈ $217.54 Million
+3.88pp
2012-12-31 1.50% CN¥20.00 Million
≈ $2.93 Million
CN¥1.33 Billion
≈ $195.30 Million
--
pp = percentage points

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic
Market Cap
$856.18 Million
CN¥5.85 Billion CNY
Market Cap Rank
#9574 Global
#2445 in China
Share Price
CN¥3.01
Change (1 day)
+2.38%
52-Week Range
CN¥2.60 - CN¥4.15
All Time High
CN¥14.40
About

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more